These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12410060)

  • 1. Severe weight gain induced by combination treatment with risperidone and paroxetine.
    Fukui H; Murai T
    Clin Neuropharmacol; 2002; 25(5):269-71. PubMed ID: 12410060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug induced akathisia, suicidal ideation and its treatment in the elderly.
    Hansen L; Wilkinson DG
    Int J Geriatr Psychiatry; 2001 Feb; 16(2):231-3. PubMed ID: 11241732
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antipsychotics--clever choices].
    Ek M; Lindefors N
    Lakartidningen; 2007 Feb 14-20; 104(7):504-8. PubMed ID: 17375681
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia.
    Miyamoto S; Miyake N; Ogino S; Endo T; Yamaguchi N
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):702-3. PubMed ID: 18081639
    [No Abstract]   [Full Text] [Related]  

  • 5. Obsessive-compulsive symptoms with risperidone.
    Mahendran R
    J Clin Psychiatry; 1999 Apr; 60(4):261-3. PubMed ID: 10221290
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone and paroxetine given singly and in combination for bipolar depression.
    Shelton RC; Stahl SM
    J Clin Psychiatry; 2004 Dec; 65(12):1715-9. PubMed ID: 15641878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Cui X; Calabrese JR; Gao K;
    J Clin Psychopharmacol; 2011 Oct; 31(5):638-42. PubMed ID: 21869688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial.
    Anghelescu I; Szegedi A; Schlegel S; Weigmann H; Hiemke C; Wetzel H
    Eur Neuropsychopharmacol; 1998 Dec; 8(4):315-20. PubMed ID: 9928923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.
    Yamauchi K; Ohta K; Taniguchi T; Ohmori T
    Gen Hosp Psychiatry; 2004; 26(3):242-3. PubMed ID: 15121355
    [No Abstract]   [Full Text] [Related]  

  • 11. Enuresis with combined risperidone and SSRI use.
    Took KJ; Buck BJ
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):840-1. PubMed ID: 8768340
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
    Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ
    Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
    Alacqua M; Trifirò G; Arcoraci V; Germanò E; Magazù A; Calarese T; Di Vita G; Gagliano C; Spina E
    Pharm World Sci; 2008 Jan; 30(1):44-50. PubMed ID: 17588130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use.
    Caley CF
    Can J Psychiatry; 1998 Apr; 43(3):307-8. PubMed ID: 9561323
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsade de pointes during combined treatment with risperidone and citalopram.
    Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W
    Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657
    [No Abstract]   [Full Text] [Related]  

  • 18. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-induced long-term weight gain in a patient with schizophrenia.
    Ziegenbein M; Kropp S
    Aust N Z J Psychiatry; 2004 Mar; 38(3):175-6. PubMed ID: 14961939
    [No Abstract]   [Full Text] [Related]  

  • 20. Gynecomastia with risperidone-fluoxetine combination.
    Benazzi F
    Pharmacopsychiatry; 1999 Jan; 32(1):41. PubMed ID: 10071182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.